1-13 of 13
Authors: Jung Ho Han
Journal Article
TMOD-34. GENERATION OF BRAIN-VESSEL-GBM ASSEMBLOIDS USING PATIENT-DERIVED GLIOBLASTOMA TISSUE
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii327, https://doi.org/10.1093/neuonc/noae165.1298
Published: 11 November 2024
Journal Article
BIOS-02. DIFFERENT GROWTH PATTERN OF VESTIBULAR SCHWANNOMAS IN NEUROFIBROMATOSIS TYPE 2 PATIENTS ACCORDING TO AGE
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii38, https://doi.org/10.1093/neuonc/noae165.0150
Published: 11 November 2024
Journal Article
SURG-09. EFFICACY OF A BIWEEKLY 3-STAGE STEREOTACTIC RADIOSURGERY FOR LARGE BRAIN METASTASES: THE EFFECT OF EGFR TYROSINE-KINASE INHIBITOR ON TUMOR RESPONSE AND CLINICAL OUTCOMES
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii253, https://doi.org/10.1093/neuonc/noac209.975
Published: 14 November 2022
Journal Article
BIOM-15. SERUM AMYLOID-β42 AS A NONINVASIVE BIOMARKER FOR PROGNOSIS AND HISTOLOGIC FEATURES OF GLIOMA
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi13, https://doi.org/10.1093/neuonc/noab196.046
Published: 12 November 2021
Journal Article
GCT-13. THE TREATMENT OUTCOMES OF INTRACRANIAL GERM CELL TUMORS WITH KSPNO PROTOCOL: SINGLE CENTER RETROSPECTIVE ANALYSIS
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii330, https://doi.org/10.1093/neuonc/noaa222.233
Published: 04 December 2020
Journal Article
GCT-12. INTRACRANIAL GROWING TERATOMA SYNDROME: CLINICAL IMPLICATION FROM SINGLE UNIVERSITY EXPERIENCES
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii330, https://doi.org/10.1093/neuonc/noaa222.232
Published: 04 December 2020
Journal Article
DDRE-23. THE COMBINATION PARP INHIBITOR OLAPARIB WITH TEMOZOLOMIDE IN AN EXPERIMENTAL GLIOBLASTOMA MODEL
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii66, https://doi.org/10.1093/neuonc/noaa215.268
Published: 09 November 2020
Journal Article
RARE-17. PRIMARY DIFFUSE LEPTOMENINGEAL GLIOMATOSIS OF HIGH GRADE TUMORS
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi225, https://doi.org/10.1093/neuonc/noz175.940
Published: 11 November 2019
Journal Article
ACTR-38. A SINGLE CENTER STUDY: LONG-TERM OUTCOMES OF COMBINED CHEMORADIATION THERAPY WITH TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA IN KOREAN PATIENT
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi21, https://doi.org/10.1093/neuonc/noz175.080
Published: 11 November 2019
Journal Article
NIMG-50. GROWTH PATTERN AND PROGNOSTIC FACTORS OF UNTREATED NONFUNCTIONING PITUITARY ADENOMAS
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi187, https://doi.org/10.1093/neuonc/noy148.776
Published: 05 November 2018
Journal Article
METB-02. EXPRESSION LEVEL OF GLUTAMINASE 2 IS ASSOCIATED WITH REGIONAL HETEROGENEITY OF 5-AMINOLEVULINIC ACID FLUORESCENCE IN GLIOBLASTOMA
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi100, https://doi.org/10.1093/neuonc/now212.416
Published: 07 November 2016
Journal Article
MNGO-07PROGNOSTIC FACTORS ASSOCIATED WITH OUTCOME OF CONSERVATIVE MANAGEMENT OF INTRACRANIAL MENINGIOMAS; A THREE-DIMENSIONAL VOLUMETRIC STUDY
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v131, https://doi.org/10.1093/neuonc/nov220.07
Published: 09 November 2015
Journal Article
Usefulness of MS-MLPA for detection of MGMT promoter methylation in the evaluation of pseudoprogression in glioblastoma patients Get access
Neuro-Oncology, Volume 13, Issue 2, February 2011, Pages 195–202, https://doi.org/10.1093/neuonc/noq162
Published: 12 November 2010
